Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page
- Check5 days agoChange DetectedA new line '2019 ( U.S. NIH Grant/Contract )' was added to the study identifiers section, indicating NIH funding for the trial. This contextual information updates the record but does not change the study design, eligibility, or outcomes as presented to users.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page now lacks the sponsor name (Sanofi), the plain-language results summary, and the 'Helpful Links Provided by' header, altering attribution and the availability of accessible summaries and navigation cues.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision label, Revision: v3.6.5, appears on the page, replacing the prior v3.6.4. This reflects a small update to the page's release notes/metadata rather than substantive content changes.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating an underlying platform update rather than changes to the page content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision changed from v3.6.2 to v3.6.3, indicating a subsequent update to the study record. This update appears to be a metadata/version change rather than a substantive alteration to the study content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.2, indicating a newer version of the study details page. This reflects a version-control update rather than a change to the trial information.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.